Navigation Links
Papworth Breathing Technique Cuts Asthma Symptoms by a Third

A sequence of breathing and relaxation exercises known as the Papworth method has been shown to reduce asthma symptoms by a third by the first randomised controlled trial to investigate the technique, which is published online ahead of print in Thorax.

Eighty five people with mild asthma were randomly assigned to receive either five sessions of treatment by the Papworth method on top of their medical care or to continue to rely on usual drug therapy.

After the sessions had finished, patients asthma symptoms were assessed using the St Georges Respiratory Symptom Questionnaire. Patients who had been treated by the Papworth method scored an average of 21.8 on the questionnaire compared with an average score of 32.8 for patients who had not received the treatment.

And this improvement in symptoms was still maintained one year later. At 12 months patients who had been treated using the Papworth method scored 24.9, while patients who had not scored 33.5.

Use of the Papworth method was associated with less depression and anxiety, and symptoms from inappropriate breathing habits were also reduced. The technique improved the relaxed breathing rate but there was no significant improvement in specific measures of lung function.

The authors say: To our knowledge, this is the first evidence from a controlled trial to demonstrate the effectiveness of the Papworth method.

The fact that no significant change was observed in objective measures of lung function suggests that five treatments of the Papworth method do not improve the chronic underlying physiological causes of asthma, but rather their manifestation.

The Papworth method of physical therapy is a series of integrated breathing and relaxation exercises developed in the 1960s. The breathing training involves a specific diaphragmatic breathing technique, emphasises nose breathing and development of a breathing pattern to suit cu
'"/>




Page: 1 2

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
3. Fear Of Flying Can Be Overcome By Deep Breathing
4. Sleep Apnea Patients Benefit from Breathing Mask
5. Breathing Exercises A Boon To Asthma Patients
6. Asthma Could be Combated by Breathing Exercises
7. Breathing Exercises Scores Over Inhalers
8. Sensitive Test Developed To Detect Breathing Problems In Very Young Children
9. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
10. Sleep-related Breathing Disorder could Indicate Depression
11. Breathing Exercises help cardiac patients to breeze through surgery
Post Your Comments:
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)...AUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Phar...maceutical company, today announced that it,has la...antiarrhythmic,indicated for the treatment and pro...llation and hemodynamically unstable ventricular,t...ular heart beat.,Sagent,s amiodarone HCl injection...
(Date:7/25/2008)...LSBAD, Calif., July 25 /PRNewswire/ -- AutoGenomic...ration statement on Form S-1 with the,Securities a...itial public,offering of shares of its common stoc...red, all of which are expected to be offered by,Au...ring, have not yet been,determined., J.P. Morgan ...
(Date:7/25/2008)... New program delivers immediate ... [24-hour telephone access to language interprete...ing multilingual solutions. , ... LLE® http://www.lle-inc.com/index.html [(L...ovider of interpretation, translation, and languag...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
... that she feared that her recent miscarriage was g...he 25-year-old, who lost her baby when she was thr...coping with bad times since the beginning of this ...ould never recover after losing the baby. "After ...
...man's performance in the bedroom, but as researche... function . This finding means that the popular d...ially save the lives of people with specific heart...was conducted by researchers at the University of ...
...l of Medicine in St. Louis have developed the firs... hoping it will help explain why the success of th...organ transplants. Ultimately, the mouse model co...therapies to prevent lung transplant rejection a ...
...as admitted that she fears that an innocent kiss w...ner said that she has major trust issues, and that...e of it, for it is a waste of her time and kisses....e is also scared of ending up having 'mouth herpes...
Other Medicine News:Health News:Viagra Improves Heart Function, Finds Study 2Health News:Viagra Improves Heart Function, Finds Study 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 2Health News:Researchers Develop First Mouse Model of Lung Transplantation 3Health News:Researchers Develop First Mouse Model of Lung Transplantation 4
(Date:7/23/2008)...TTLE, July 23 /- Sound Pharmaceutical...ication with the FDA for the clinical,testing of a...tion of,chemotherapy induced hearing loss or ototo...005, will be tested in advanced stage lung cancer,...um based chemotherapy.,This marks the second devel...
(Date:7/23/2008)...TTLE, July 23 /- Dendreon C...t expects the Independent Data,Monitoring Committe...lysis,of overall survival relating to the Company,...Carcinoma Treatment, also known as D9902B) clinica... the Company,s investigational,active cellular imm...
(Date:7/22/2008)...est awards under Therapeutics Development Initiati...ions to 23; next deadline January 20,2009, NEW Y... its mission to,speed delivery of transformative t...Michael J. Fox Foundation for Parkinson,s Research...industry research teams. The awards,were granted u...
(Date:7/22/2008)...Geoffrey Allan Will Stress the Importance to Patie...ics Approval Pathway, RICHMOND, Va., July 22 /PRN...) a developer of follow-on biologics and biopharma....D., CEO of Insmed, will present at a,Congressiona...he,significant need for establishing an approval p...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD 385 1Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD 385 2Adult offspring of parents with PTSD have lower cortisol levels 381 1Adult offspring of parents with PTSD have lower cortisol levels 381 24 Star Gen Barry McCaffrey Former U S Drug Czar to Address National Drug Crisis Keynote Grand Opening of New Allenwood PA National Model Detox C 377 14 Star Gen Barry McCaffrey Former U S Drug Czar to Address National Drug Crisis Keynote Grand Opening of New Allenwood PA National Model Detox C 377 2American Chemical Societys Weekly Presspac Aug 29 2007 218 1American Chemical Societys Weekly Presspac Aug 29 2007 218 2American Chemical Societys Weekly Presspac Aug 29 2007 218 3American Chemical Societys Weekly Presspac Aug 29 2007 218 4American Chemical Societys Weekly Presspac Aug 29 2007 218 5American Chemical Societys Weekly Presspac Aug 29 2007 218 6American Chemical Societys Weekly Presspac Aug 29 2007 218 7American Chemical Societys Weekly Presspac Aug 29 2007 218 8
...NA, Calif.--(BUSINESS WIRE)--Mar 20, 2007 - Caland...mpany and a,majority-owned subsidiary of Arrowhead... publication in the Proceedings of the,National Ac...f the,NAS, of the first non-human primate study to... siRNA therapeutic candidate that is a,nanoparticl...
...FIELD, N.J., March 20, 2007 /PRNewswire-FirstCall/...as shown potential to,act as a potent payload in a...o the latest edition of the Handbook of Therapeuti...ews immunotoxins, Susanna,Rybak, Ph.D. summarizes ...ty and potency of ONCONASE improves in a number of...
Other Medicine Technology:Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4
The NOW® Malaria Test is a field or laboratory test for the differential diagnosis of a Malaria infection. It is intended for the detection of circulating Plasmodium falciparum (P.f.) antigen
Ultraview 1700 Central Monitor
...tient Care Monitor (PCM) and Central Station provi...PCM extends the cardiac cath or electrophysiology ...ath and/or EP procedures, providing both physiomon...device either standalone or on its own network. W...
...nitoring via the Acuity central station and Welch ...nvert non-monitored beds into centrally monitored ...t both wireless and hardwired monitors and clinica...ities from a community hospital to a teaching inst...
Medicine Products: